HealthTech

VectorVision

VectorVision Raises $500M Growth to Transform HealthTech

$500M Growth
Total Raised
Growth
Latest Round
2023
Founded
250-500
Employees
Philadelphia, PA
1 min read

Quick Facts

Valuation
$10B
Latest Round Size
$500M Growth
Latest Round Date
October 2025

VectorVision Raises $500M Growth in Latest Funding Round

VectorVision has successfully closed a $500M Growth funding round, marking a significant milestone in the company's growth trajectory. The round was led by Andreessen Horowitz, with participation from Founders Fund.

Company Overview

Founded in 2023 and headquartered in Philadelphia, PA, VectorVision has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $10B, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $500M Growth
  • Valuation: $10B
  • Lead Investor: Andreessen Horowitz

Future Outlook

As VectorVision moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Andreessen Horowitz
Venture Capital
Leading venture capital firm investing in technology companies
Founders Fund
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Sarah Kim
Sarah Kim
Healthcare and biotech investment analyst with expertise in Series B+ rounds and strategic partnerships.